Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Arceci

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Blood|September 15, 1992
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotypeR J Arceci, K Stieglitz, B E Bierer
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 1, 1991
Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation developmentS Pampfer, R J Arceci, J W Pollard
Hematology/Oncology Clinics of North America|April 30, 1998
Controversies and new approaches to treatment of Langerhans cell histiocytosisR J Arceci, M K Brenner, J Pritchard
International Review of Cytology|December 7, 2006
Biology of Langerhans cells and Langerhans cell histiocytosisG I Bechan, R M Egeler, R J Arceci
Medical and Pediatric Oncology|July 1, 1997
Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?K E Rosenzweig, R J Arceci, N J Tarbell
Seminars in Perinatology|September 4, 1999
Congenital and neonatal leukemiaJ E Sande, R J Arceci, B C Lampkin
Cell|September 1, 1976
The programmed switch in lysine-rich histone synthesis at gastrulationR J Arceci, D R Senger, P R Gross
Plastic and Reconstructive Surgery|August 1, 1996
Langerhans cell histiocytosis: an uncommon disease commonly manifesting in the craniofacial skeletonD Martinez-Perez, J B Mulliken, R J Arceci
Oncogene|August 9, 2001
STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicityZ Q Ning, J Li, M McGuinness, et al.
The Journal of Clinical Investigation|June 1, 1995
Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejectionU Utans, R J Arceci, Y Yamashita, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Blood|September 15, 1992
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotypeR J Arceci, K Stieglitz, B E Bierer
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 1, 1991
Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation developmentS Pampfer, R J Arceci, J W Pollard
Hematology/Oncology Clinics of North America|April 30, 1998
Controversies and new approaches to treatment of Langerhans cell histiocytosisR J Arceci, M K Brenner, J Pritchard
International Review of Cytology|December 7, 2006
Biology of Langerhans cells and Langerhans cell histiocytosisG I Bechan, R M Egeler, R J Arceci
Medical and Pediatric Oncology|July 1, 1997
Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?K E Rosenzweig, R J Arceci, N J Tarbell
Seminars in Perinatology|September 4, 1999
Congenital and neonatal leukemiaJ E Sande, R J Arceci, B C Lampkin
Cell|September 1, 1976
The programmed switch in lysine-rich histone synthesis at gastrulationR J Arceci, D R Senger, P R Gross
Plastic and Reconstructive Surgery|August 1, 1996
Langerhans cell histiocytosis: an uncommon disease commonly manifesting in the craniofacial skeletonD Martinez-Perez, J B Mulliken, R J Arceci
Oncogene|August 9, 2001
STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicityZ Q Ning, J Li, M McGuinness, et al.
The Journal of Clinical Investigation|June 1, 1995
Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejectionU Utans, R J Arceci, Y Yamashita, et al.
Pageof 6